Podcast: This Week in Managed Care—CAR T Therapy Coverage and Other Health News

Article

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included CMS' proposal to cover chimeric antigen receptor T-cell therapy; a study faulting the FDA’s handling of fentanyl oversight; and breast surgeons calling for genetic testing for all patients with breast cancer.

You may need to log in to the website to access this podcast.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:

CMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy

Study Criticizes FDA Safety Oversight of Rapid-Release Fentanyl

Breast Surgeons Seek Genetic Testing for All Patients With Breast Cancer

Greater Diet Drink Consumption Heightens Stroke Risk in Postmenopausal Women

Advancing Quality Oncology Care in the Evolving Value-Based Care Landscape

Read more about the stories in this podcast:

Recent Videos
David-Alexandre C. Gros, MD, Eledon’s chief executive officer
Robert Califf, MD, MACC, a cardiologist and former FDA commissioner
Natalie Goedeker, CPNP, on Handling Neuromuscular Gene Therapy at Real-World Sites
David-Alexandre C. Gros, MD, Eledon’s chief executive officer
Michael Flanagan, PhD, chief scientific officer at Avidity
David Barrett, JD, the chief executive officer of ASGCT
David-Alexandre C. Gros, MD, Eledon’s chief executive officer
David Barrett, JD, the chief executive officer of ASGCT
Alfred L. Garfall, MD, MS, associate professor of medicine (hematology-oncology) and director, Autologous Hematopoietic Cell Transplantation, Cell Therapy and Transplant Program, Hospital of the University of Pennsylvania; and section chief, Multiple Myeloma, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania,
Reena Sharma, MD, an adult metabolic consultant at Salford Royal Hospital
Related Content
David-Alexandre C. Gros, MD, Eledon’s chief executive officer

The Work Necessary to Bring Porcine Kidney Transplant to the Clinic

David-Alexandre C. Gros, MD;Noah Stansfield
April 6th 2025
Article

David-Alexandre Gros, MD, the chief executive officer of Eledon Pharmaceuticals, also discussed other future plans for the company.

ImmunoLogic

ImmunoLogic, Episode 2: "Charting New Frontiers in CAR T-Cell Safety" With Bruce Levine, PhD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Noah Stansfield;Matt Hoffman
March 11th 2025
Podcast

In Episode 2 of ImmunoLogic, Bruce Levine, PhD, discussed the current the risk-benefit-ratio for CAR-T therapy.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – April 4, 2025

Noah Stansfield
April 4th 2025
Article

Review top news and interview highlights from the week ending April 4, 2025.

ImmunoLogic

ImmunoLogic, Episode 1: "Chemo-Free Lymphoma? Seriously?" With Stephen J. Schuster, MD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Noah Stansfield;Matt Hoffman
January 31st 2025
Podcast

In Episode 1 of ImmunoLogic, Stephen J. Schuster, MD, discussed the potential of treating lymphoma without chemotherapy.

European Medicines Agency Requests Pause on Trials for Sarepta’s DMD Gene Therapy Elevidys

European Medicines Agency Requests Pause on Trials for Sarepta’s DMD Gene Therapy Elevidys

Noah Stansfield
April 3rd 2025
Article

The move was made in relation to the previously-announced death of a US teenager who received the therapy.

Around the Helix: Cell and Gene Therapy Company Updates – April 2, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 2, 2025

Noah Stansfield
April 2nd 2025
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

© 2025 MJH Life Sciences

All rights reserved.